Trials / Completed
CompletedNCT06206629
Contralateral R1 in Amyotrophic Lateral Sclerosis
Evaluation of Contralateral R1 Component of the Blink Reflex in Patients With Amyotrophic Lateral Sclerosis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (actual)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Accepted
Summary
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease affecting both upper and lower motor neurons. Electroneuromyography is an important tool for the diagnosis. Previous studies have shown that different components of the blink reflex, such as the latencies of homo- and contralateral R2 responses can be affected. Studies have found that a contralateral R1 component can appear in neurological diseases with affection of the central nervous system especially upper motor neuron, such as HTLV1 infection. Thus, you aim to determine if a contralateral R1 component could be present in ALS.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | blink reflex evaluation | A blink reflex evaluation will be performed in all subjects |
Timeline
- Start date
- 2024-02-15
- Primary completion
- 2024-09-05
- Completion
- 2024-09-05
- First posted
- 2024-01-16
- Last updated
- 2024-10-09
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT06206629. Inclusion in this directory is not an endorsement.